BioXcel Therapeutics
BTAI
BTAI
73 hedge funds and large institutions have $26.1M invested in BioXcel Therapeutics in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 26 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
35% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 26
44% less call options, than puts
Call options by funds: $422K | Put options by funds: $754K
Holders
73
Holding in Top 10
–
Calls
$422K
Puts
$754K
Top Buyers
| 1 | +$1.05M | |
| 2 | +$279K | |
| 3 | +$274K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$254K |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$135K |
Top Sellers
| 1 | -$1.37M | |
| 2 | -$455K | |
| 3 | -$322K | |
| 4 |
Squarepoint
New York
|
-$168K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$161K |